• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ARIAD Pharmaceuticals Inc

+ Add to Watchlist

ARIA:US

6.6200 USD 0.2600 4.09%

As of 13:23:19 ET on 12/18/2014.

Company Profile for ARIAD Pharmaceuticals Inc (ARIA)

ARIAD Pharmaceuticals, Inc. is a global oncology company focused on the discovery, development and commercialization of medicines to transform the lives of cancer patients. The Company's approach to structure-based drug design has led to several molecularly targeted medicines for drug-resistant or difficult-to-treat cancers.

Contact Information

ARIAD Pharmaceuticals Inc

26 Landsdowne Street
Cambridge, MA 02139-4234
United States
Phone: 1-617-494-0400
Fax: 1-617-494-1828

Key Executives for ARIAD Pharmaceuticals Inc (ARIA)

Harvey J BergerChairman/President/CEOTimothy P ClacksonChief Scientific Ofcr/Pres:R&D
Edward M FitzgeraldExec VP/CFO/TreasurerMartin J Duvall "Marty"Exec VP/Chief Commercial Ofcr
Hugh M ColeSenior VP/Chief Business OfcrDavid L BersteinSenior VP/Chief Intellectual
Frank G HaluskaSenior VP/Chief Medical OfcrMaria E CantorSenior VP:Corporate Affairs
Daniel M BollagSenior VP:Regulatory Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil